106 related articles for article (PubMed ID: 2306330)
1. Cerebral laterality and depression: relations of perceptual asymmetry to outcome of treatment with tricyclic antidepressants.
Bruder GE; Stewart JW; Voglmaier MM; Harrison WM; McGrath P; Tricamo E; Quitkin FM
Neuropsychopharmacology; 1990 Feb; 3(1):1-10. PubMed ID: 2306330
[TBL] [Abstract][Full Text] [Related]
2. Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men.
Bruder GE; Stewart JW; McGrath PJ; Deliyannides D; Quitkin FM
Neuropsychopharmacology; 2004 Sep; 29(9):1752-61. PubMed ID: 15238992
[TBL] [Abstract][Full Text] [Related]
3. Dichotic listening before and after fluoxetine treatment for major depression: relations of laterality to therapeutic response.
Bruder GE; Otto MW; McGrath PJ; Stewart JW; Fava M; Rosenbaum JF; Quitkin FM
Neuropsychopharmacology; 1996 Aug; 15(2):171-9. PubMed ID: 8840353
[TBL] [Abstract][Full Text] [Related]
4. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
Feighner JP; Herbstein J; Damlouji N
J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
[TBL] [Abstract][Full Text] [Related]
5. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
Rosan TA; Mesones HL; Brengio F
Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy.
Tiller JW; Mitchell P; Burrows GD
Aust N Z J Psychiatry; 1992 Jun; 26(2):327-9. PubMed ID: 1642632
[No Abstract] [Full Text] [Related]
7. The Newcastle Anxiety Depression Diagnostic Index in relationship to the effects of monoamine oxidase inhibitors and tricyclic antidepressants.
Davidson J; Pelton S; Krishnan RR; Allf B
J Affect Disord; 1986; 11(1):51-8. PubMed ID: 2944928
[TBL] [Abstract][Full Text] [Related]
8. Relative effectiveness of tricyclic antidepressant versus monoamine oxidase inhibitor monotherapy for treatment-resistant depression.
Kim T; Xu C; Amsterdam JD
J Affect Disord; 2019 May; 250():199-203. PubMed ID: 30861462
[TBL] [Abstract][Full Text] [Related]
9. [Combining a classic monoamine oxidase inhibitor with a tricyclic antidepressant in therapy-resistant depression: a case report and literature review].
Schipper P; Vanmolkot L; Peeters FP
Tijdschr Psychiatr; 2016; 58(12):886-890. PubMed ID: 27976787
[TBL] [Abstract][Full Text] [Related]
10. Cerebral laterality and depression: differences in perceptual asymmetry among diagnostic subtypes.
Bruder GE; Quitkin FM; Stewart JW; Martin C; Voglmaier MM; Harrison WM
J Abnorm Psychol; 1989 May; 98(2):177-86. PubMed ID: 2708661
[TBL] [Abstract][Full Text] [Related]
11. Rational use of antidepressants.
Perry PJ; Alexander B
Prim Care; 1987 Dec; 14(4):773-83. PubMed ID: 3324134
[TBL] [Abstract][Full Text] [Related]
12. Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy.
Ponto LB; Perry PJ; Liskow BI; Seaba HH
Am J Hosp Pharm; 1977 Sep; 34(9):954-61. PubMed ID: 333909
[TBL] [Abstract][Full Text] [Related]
13. Combined MAOI-tricylic antidepressant treatment: a controlled trial.
White K; Razani J; Simpson G; Rebal R; Sloane RB; O'Leary J; Palmer R
Psychopharmacol Bull; 1982 Oct; 18(4):180-1. PubMed ID: 6760234
[No Abstract] [Full Text] [Related]
14. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
[TBL] [Abstract][Full Text] [Related]
15. Tricyclic nonresponders: phenomenology and treatment.
Roose SP; Glassman AH; Walsh BT; Woodring S
Am J Psychiatry; 1986 Mar; 143(3):345-8. PubMed ID: 3953869
[TBL] [Abstract][Full Text] [Related]
16. [MAO inhibitors and depressive disorders today].
Bonamy D; Olié JP; Lôo H
Encephale; 1983; 9(2):123-36. PubMed ID: 6641614
[TBL] [Abstract][Full Text] [Related]
17. An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression.
Birkenhäger TK; Vegt M; Nolen WA
Pharmacopsychiatry; 1997 Jan; 30(1):23-6. PubMed ID: 9065966
[TBL] [Abstract][Full Text] [Related]
18. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
Kahn D; Silver JM; Opler LA
J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
[TBL] [Abstract][Full Text] [Related]
19. [Tricyclics, MAOI and electroshock therapy in the treatment of depressive syndromes].
Carolei A; Frontoni M
Clin Ter; 1981 Jul; 98(1):75-86. PubMed ID: 7018824
[No Abstract] [Full Text] [Related]
20. Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?
Stewart JW; McGrath PJ; Quitkin FM
Neuropsychopharmacology; 2002 Feb; 26(2):237-45. PubMed ID: 11790519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
